市场调查报告书
商品编码
1497807
全球天冬酰胺市场:按类型、应用-预测(2024-2030)Asparagine Market by Type (Asparagine Anhydrous, Asparagine Monohydrate), Application (Food & Beverage, Pharmaceutical) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年全球天门冬胺酸市场规模将达118.1亿美元,2024年将达124亿美元,复合年增长率为5.29%,2030年将达169.6亿美元。
天冬酰胺是一种胺基酸,在蛋白质生物合成中发挥重要作用。它是大脑发育和功能的重要组成部分,也是神经传导物质的前体。天冬酰胺市场涵盖生物技术、食品和饮料、製药和动物饲料等各个行业,展示了其广泛的用途。分析市场需要深入了解其应用、最终用途、市场规模、成长机会因素、限制、创新潜力等。人们对营养食品健康意识的增强以及製药业研发投资的增加正在推动市场的成长。食品饮料产业不断的技术创新也在推动市场发展。原料价格的波动、有关天冬酰胺使用的严格法规和标准限制了市场的成长。含天冬酰胺的新型药物製剂的市场开拓、精准医疗和标靶治疗的兴起预计将为市场提供机会。
主要市场统计 | |
---|---|
基准年[2023] | 118.1亿美元 |
预测年份 [2024] | 124亿美元 |
预测年份 [2030] | 169.6亿美元 |
复合年增长率(%) | 5.29% |
区域洞察
美洲天冬酰胺市场的特点是北美先进的生物技术领域。美国生产和消费天冬酰胺,主要用于製药和食品工业。南美市场正在兴起,巴西食品添加剂应用和研究对天冬酰胺的需求不断增加。北美有关食品添加剂和临床营养的严格法规正在推动对高纯度天冬酰胺的需求。在以中国、日本和印度主导的亚太地区,由于製药、食品以及食品和饮料行业的成长,天冬酰胺市场正在迅速扩大。中国大规模的生产能力使其成为国内外天冬酰胺的重要供应国。该地区正在经历营养和保健食品行业的成长,推动了对天冬酰胺等氨基酸的需求。不断变化的监管环境和不断增强的消费者健康意识正在进一步塑造市场动态。在欧洲、中东和非洲,欧洲引领天门冬胺酸的成熟市场,特别是在製药和食品产业。人口的稳定老化导致该地区对含天冬酰胺的营养食品和肠外营养的巨大需求。中东和非洲市场有待开拓,但由于健康意识的提高和饮食习惯的改变,具有成长潜力。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在天门冬胺酸市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对天冬酰胺市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前天冬酰胺市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[183 Pages Report] The Asparagine Market size was estimated at USD 11.81 billion in 2023 and expected to reach USD 12.40 billion in 2024, at a CAGR 5.29% to reach USD 16.96 billion by 2030.
Asparagine, an amino acid, plays a fundamental role in the biosynthesis of proteins. It is an essential component required for the development and functioning of the brain and is a precursor to neurotransmitters. The asparagine market spans various industries, including biotechnology, food and beverage, pharmaceuticals, and animal feed, showcasing its broad spectrum of utilizations. Analyzing the market requires insights into its applications, end-uses, market scope, growth opportunity factors, limitations, and potential areas of innovation. Rising health consciousness for dietary supplements and increased investment in R&D in the pharmaceutical industry are driving the market growth. Ongoing innovations in the food and beverage industry are also propelling the market. Fluctuations in the prices of raw materials and stringent regulations and standards regarding the use of asparagine are restricting market growth. The development of novel pharmaceutical formulations containing asparagine and the rise in precision medicine and targeted therapies are expected to create opportunities in the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.81 billion |
Estimated Year [2024] | USD 12.40 billion |
Forecast Year [2030] | USD 16.96 billion |
CAGR (%) | 5.29% |
Regional Insights
The Asparagine market in the Americas is characterized by advanced biotechnology sectors, particularly in North America. The United States produces and consumes Asparagine, predominantly for the pharmaceuticals and food industries. South America's market is emerging, with Brazil showing increasing demand for Asparagine in food additive applications and research. Stringent regulations on North American food additives and clinical nutrition bolster the demand for high-purity Asparagine. The Asia-Pacific, led by China, Japan, and India, has a rapidly expanding asparagine market due to its growing pharmaceutical, food, and beverage industries. China's large-scale manufacturing capabilities make it a significant supplier of Asparagine domestically and globally. The region is witnessing growth in nutrition and health supplement sectors, driving the need for amino acids such as Asparagine. The evolving regulatory landscape and increasing consumer health consciousness further shape the market dynamics. In EMEA, Europe leads with a mature market for Asparagine, particularly within the pharmaceutical and nutraceutical industries. The steadily aging population contributes to the region's significant demand for dietary supplements and parenteral nutrition, which includes Asparagine. The market needs to be developed in the Middle East and Africa but presents potential for growth with rising health awareness and changing dietary habits.
Market Insights
The market dynamics represent an ever-changing landscape of the Asparagine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Asparagine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Asparagine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Jazz Pharmaceuticals plc has announced a significant development with the European Commission's approval of Enrylaze (JZP458), a recombinant Erwinia asparaginase, under the brand name Rylaze in the U.S. and Canada. This endorsement authorizes Enrylaze for use within multi-agent chemotherapy treatments for acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) for those aged one month and older who are intolerant and have an inadequate response to E. coli-derived asparaginases. [Published On: 2023-09-21]
Kaimisi New Material and Bicells to build 2,000 t per year L-asparagine project and 100 t per year GABA project
Shandong Kaimisi New Material Technology Co., Ltd. has announced the successful publication of their Environmental Impact report, approved on October 11 by the Dongying Municipal Ecological Environment Bureau, for a pioneering L-asparagine production project using biofermentation. The project, situated in Dongying City's Economic Development Zone, sees an investment of approximately USD 28.17 million aimed at erecting a state-of-the-art facility capable of yielding 2,000 tons per annum (t/a) of this essential amino acid, known for its extensive applications across the food, medical, and environmental protection industries. [Published On: 2022-01-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Asparagine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Asparagine Market, highlighting leading vendors and their innovative profiles. These include BioVendor Group, Creative Enzymes, Duchefa Biochemie B.V., Jazz Pharmaceuticals, Inc., LGC Limited, medac GmbH, Merck KGaA, MP Biomedicals, LLC, Porton Biopharma Limited, Taj Pharmaceuticals Ltd., Tokyo Chemical Industry (India) Pvt. Ltd., and VWR International, LLC.
Market Segmentation & Coverage